Goodwin advised DNA Script on the deal. Dentons advised Bpifrance Large Venture. August Debouzy advised Coatue Management, Catalio Capital Management and Fidelity Management and Research. DNA...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Agronutris on the deal. UGGC Avocats advised Bpifrance Investissement and Mirova on the deal. Agronutris announced its €100 million fundraising. The company raised 50 million...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Cathay Health on the deal. TISSIUM, a privately-owned medtech company developing biomorphic programmable polymers for tissue reconstruction, has closed a Series C round...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Protera on the deal. Protera announced its €3,5 million new Series A financing. The round was led by Sofinnova Partners and SOSV – existing...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Meletios Therapeutics on the deal. Meletios Therapeutics, a French biotechnology company specialized in the research and development of next-generation antiviral treatments, announced a...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Assurly on the deal. Assurly announced its 6 million financing round from a network of English entrepreneurs, Cleverton Ventures, as well as French business...
You must be a Standard 1 Year member to access this content.
IN BRIEF: Dentons, Goodwin Procter, advised on the matter. Dentons advised Zama with a team including Pascal Chadenet (Picture – Corporate M&A). Goodwin Procter advised Metaplanet...
You must be a Standard 1 Year member to access this content.
IN BRIEF: Dentons, Goodwin Procter, advised on the matter. Dentons advised Zama with a team including Pascal Chadenet (Picture – Corporate M&A). Goodwin Procter advised Metaplanet...
You must be a Standard 1 Year member to access this content.
IN BRIEF: Dechert, advised on the matter. Dechert advised Arkhn with a team including Anne-Charlotte Rivi?e (Picture – Corporate M&A). Read the full article on Global...
You must be a Standard 1 Year member to access this content.
IN BRIEF: Dechert, PMLC Avocats, advised on the matter. Dechert advised Biomunex Pharmaceuticals with a team including Anne-Charlotte Rivi?e (Picture – Corporate M&A). PMLC Avocats advised...
You must be a Standard 1 Year member to access this content.
IN BRIEF: Dechert, advised on the matter. Dechert advised Karista SAS with a team including Anne-Charlotte Rivi?e (Picture – Corporate M&A). Read the full article on...
You must be a Standard 1 Year member to access this content.
Dechert advised the investor on the deal. Kurma Partners, BNP Paribas Développement and Bpifrance through its fund Patient Autonomy, completed their investment of a total amount of...
You must be a Standard 1 Year member to access this content.
